Glaxosmithkline Capital Inc

CIK 1224462 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Glaxosmithkline Capital Inc.

Recent SEC filings

FiledFormAccession number
Sep 10, 2026424B20001193125-26-387354
Sep 9, 2026FWP0001193125-26-385861
Sep 8, 2026424B20001193125-26-384490
Sep 8, 20266-K0001193125-26-384439
Mar 18, 2025CERT0000876661-25-000200
Mar 13, 20258-A12B0001193125-25-053838
Mar 13, 20256-K0001193125-25-053830
Mar 10, 2025424B20001193125-25-050728
Mar 7, 2025FWP0001193125-25-048578
Mar 6, 2025424B20001193125-25-047959
Mar 25, 2024F-3ASR0001193125-24-076338
Mar 15, 2023EFFECT9999999995-23-000582
Mar 10, 2023POS AM0001193125-23-067243
Sep 15, 202225-NSE0000876661-22-000756
Sep 1, 202225-NSE0000876661-22-000732
Aug 16, 20226-K0001140361-22-029786
Aug 16, 20226-K0001140361-22-029787
Mar 26, 2021F-3ASR0001193125-21-096095
May 21, 2018CERT0000876661-18-000564
May 17, 201825-NSE0000876661-18-000539
May 15, 20186-K0001193125-18-164071
May 15, 20188-A12B0001193125-18-164266
May 14, 2018424B20001193125-18-162878
May 11, 2018FWP0001193125-18-160226
May 11, 2018FWP0001193125-18-160222